Pay with

USD

Supports Visa, Mastercard, SEPA & more

Flexible trading, zero fees

Use your crypto for payments worldwide

Basic

Trade crypto freely

Magnify your profit with leverage

Convert & Auto-Invest

Trade any size with no fees and no slippage

Get exposure to leveraged positions simply

Pre-Market Trading

Trade new tokens before listing

Advanced

Trade on-chain with Gate Wallet

Smart access to new on-chain tokens

Smart strategies with automated trading

Follow expert trading strategies

CrossEx Trading

One margin balance, shared across platforms

Access hundreds of perpetual contracts

One platform for global traditional assets

Trade European-style vanilla options

Unified Account

Maximize your capital efficiency

Introduction to Futures Trading

Learn the basics of futures trading

Join events to earn rewards

Use virtual funds to practice risk-free trading

Stock CFD Derivatives

Access real US stocks and ETFs

Trade quality Hong Kong-listed stocks

Real Korean stocks and top assets

High leverage, 24/7 trading

Tokenized Stocks

Backed by real stock assets

Unlock full access to global stock IPOs

Mint GUSD for Treasury RWA yields

Stocks Activities

Trade Popular Stocks and Unlock Generous Airdrops

Launch

Collect candies to earn airdrops

Quick staking, earn potential new tokens

Hold GT and get massive airdrops for free

Unlock full access to global stock IPOs

Trade on-chain assets and earn airdrops

Earn futures points and claim airdrop rewards

Investment

Earn interest with idle tokens

Auto-invest on a regular basis

Dual Investment

Profit from market volatility

Earn rewards with flexible staking

Pledge one crypto to borrow another

One-stop lending hub

Premium wealth growth plans

Take control of your financial future

Top-tier quant strategies

Stake cryptos to earn in PoS products

No-liquidation leverage

Mint and Redeem Anytime, No Redemption Fees

Post, share, and explore crypto trends

Live crypto market analysis

Chat with crypto traders

What is happening in crypto

More

Promotions

Activity Center

Participate in activities to earn rewards

Invite friends to earn referral rewards

Affiliate Program

Earn exclusive commission rewards

Grow influence and earn airdrops

Real-time platform updates

Crypto industry articles

Huge fee discounts

Asset Management

One‑stop asset management solution

Enterprise digital asset solutions

Developers (API)

Connects to the Gate application ecosystem

OTC Bank Transfer

Deposit and withdraw fiat

Generous API rebate mechanisms

AI

Your all-in-one conversational AI partner

Use Gate AI directly in your social App

Gate Blue Lobster, ready to go

Gate for AI Agent

AI infrastructure, Gate MCP, Skills, and CLI

Gate Skills Hub

From office tasks to trading, the all-in-one skill hub makes AI even more useful.

Others

Find FAQs and help guides

Learn about crypto investing

Grow with the champions

Proof of Reserves

Gate promises 100% proof of reserves

Keep your assets secure

Samsung Biologics Offers $1.8B Cash Bid for Swiss PolyPeptide Group

2026-07-20 13:55:15

Samsung Biologics3.71%

Samsung Biologics announced an all-cash offer of 1.46 billion Swiss francs (approximately $1.8 billion) to acquire PolyPeptide Group, a Swiss-based specialist in peptide active pharmaceutical ingredients. The acquisition aims to expand Samsung's pipeline in peptide therapeutics and enter the lucrative weight-loss drug market. The company expects to complete the transaction by year-end.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.

Related News

Samsung BioLogics Acquires PolyPeptide Group for 2.7 Trillion Won on July 20

HLG Genomics Files for KOSDAQ Listing at 21,500 Won, Eyes July 24 Debut With 667:1 Subscription Ratio

Single-Stock Leverage ETFs Draw 73T Won in Korea, Down 45%, as Government Raises Entry Bar

HLG Genomics Lists on KOSDAQ on July 24 at 21,500 Won Per Share

In-Depth Analysis

Samsung SK Hynix Leveraged ETFs Drop 70%, Korean Retail Investors Face Losses

Lucas Bennett07-20 12:23

Samsung Biologics to acquire PolyPeptide for KRW 2.7 trillion, creating South Korea’s largest pharma M&A deal

Market Whisper07-20 02:11

Samsung Biologics Acquires PolyPeptide Group for 2.7 Trillion Won in Largest Korean Pharma M&A

Lucas Bennett07-20 00:51

Comment

0/400

No comments